21
© Renub Research Page 1 of 21 Influenza Vaccines Market & Forecast - Worldwide Analysis Renub Research www.renub.com Published: November, 2014 Copyright © 2014 Renub Research All Rights Reserved United StatesJapanChinaIndia BrazilNetherlandsGermanyFrance ItalySpainDenmarkSwedenPortugal LuxembourgLithuaniaUnited Kingdom PolandNorwayRomaniaEstonia FinlandHungaryIrelandIceland LatviaMaltaSlovakiaSlovenia New ZealandAustralia

Influenza Vaccines Market & Forecast - Worldwide Analysis

Embed Size (px)

Citation preview

© Renub Research Page 1 of 21

Influenza Vaccines Market & Forecast -

Worldwide Analysis

Renub Researchwww.renub.com

Published: November, 2014Copyright © 2014 Renub Research – All Rights Reserved

United States…Japan…China…IndiaBrazil…Netherlands…Germany…FranceItaly…Spain…Denmark…Sweden…PortugalLuxembourg…Lithuania…United KingdomPoland…Norway…Romania…EstoniaFinland…Hungary…Ireland…IcelandLatvia…Malta…Slovakia…SloveniaNew Zealand…Australia

© Renub Research Page 2 of 21

Influenza Vaccines Market Analysis

The Influenza vaccines market represent an attractive market characterize by sturdy growth

prospects. Increasing awareness, growing vaccination coverage in the emerging countries,

rising government support for immunization against Seasonal Influenza and increased focus on

the production of treatments for vulnerable populations by introducing new vaccines and

vaccines with a better route of administration are the main drivers to galvanized Influenza

vaccines market.

Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza

vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the

other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010

primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of

Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu

epidemic.

United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging

countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5

to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.

In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the

highest sales figures and likely to maintain leadership position in the Seasonal Influenza

vaccines market.

Renub Research study titled “Influenza Vaccines Market & Forecast - Worldwide

Analysis” provides a comprehensive assessment of the fast-evolving, high-growth of World

Influenza Vaccines Landscape. This 179 page report with 140 Figures and 7 Tables examines

the following segments for Influenza Vaccines Market

Worldwide Influenza vaccines market (2009 - 2019)

Worldwide Seasonal Influenza vaccines market has been covered from (2009 – 2019)

© Renub Research Page 3 of 21

Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 –

2011)

Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 -

2019)

Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines

(2009 - 2019)

Top 30 countries Seasonal Influenza vaccines market (2008 – 2019)

Top Brands Seasonal Influenza vaccines (Fluarix/Flulaval, Afluria/Fluvax,

FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone) Sales Performance & Forecast

Top Merger & Acquisition deals in Influenza Vaccines Market

Key drivers of growth in the Worldwide Influenza Vaccines Market

Key challenges faces by Influenza Vaccines Market All the 30 Countries Studied in the Report are as Follows

1. United States

2. Japan

3. China

4. India

5. Brazil

6. Netherlands

7. Germany

8. France

9. Italy

10. Spain

11. Denmark

12. Sweden

13. Portugal

14. Luxembourg

15. Lithuania

16. United Kingdom

17. Poland

18. Norway

19. Romania

20. Estonia

21. Finland

22. Hungary

23. Ireland

24. Iceland

25. Latvia

26. Malta

27. Slovakia

28. Slovenia

29. Australia

30. New Zealand

© Renub Research Page 4 of 21

Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows

1. Fluarix / Flulaval

2. Afluria/Fluvax

3. FluMist/Fluenz

4. Influvac

5. Fluvirin / Flucelvax

6. Fluzone

Data Sources

This report is built using data and information sourced from proprietary databases, primary and

secondary research and in-house analysis by Renub Research team of industry experts. Primary

sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-

printable sources like search engines, News websites, Government Websites, Trade Journals,

White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,

Industry Portals, Industry Associations and access to more than 500 paid databases.

© Renub Research Page 5 of 21

About Us

RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in

international Business-to-Business Researches, Surveys, Business and Consulting. Throughout

the years we have acquired expertise in most market sectors, including Information Technology

(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,

Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer

Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and

Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information

Technology, Environmental Science and many more. Our research help make the business

decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We

support many blue chip companies by providing them findings and perspectives across a wide

range of markets. Our research reports offer a blend of information insight, analysis and

forecasting that is essential in today’s ultra-competitive markets.

For more information on us or to view any of our sample work you can mail

us at [email protected]

© Renub Research Page 6 of 21

Published

By

RReennuubb RReesseeaarrcchh

1st Floor,

C-86, Sector–10

Noida – 201301

Phone: +91-120-421-9822, 254-5750 (India)

+1-678-302-0700 (USA)

Fax : +91-120-424-9780

Email: [email protected]

www.renub.com

© Influenza Vaccines Market & Forecast – Worldwide Analysis

Renub Research, 2014

Edition 1.0

All rights reserved. This publication is protected

by copyright. No part of it may be reproduced, stored

in a retrieval system or transmitted, in any form or by

any means, electronic mechanical, photocopying,

recording or otherwise without the prior written

permission of the publishers

© Renub Research Page 7 of 21

Table of Contents

1. Executive Summary

2. Worldwide Influenza Vaccines Market & Forecast

2.1 Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

2.2 Merger and Acquisition in Influenza Vaccines Market

3. Worldwide – Seasonal Influenza Vaccines Market & Forecast

4. Worldwide – Swine Flu (H1N1) Influenza Vaccines Market

5. Worldwide Influenza Vaccines Market Share & Forecast

5.1 Segment wise – Influenza Vaccines Market Share & Forecast

5.2 Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines

Share & Forecast

5.3 Countries wise – Seasonal Influenza Vaccines Market Share & Forecast

6. Geographical Segmentation – Seasonal Influenza Vaccines Market & Vaccination Coverage

(2008 – 2019)

6.1 United States

6.1.1 United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.1.2 United States – Seasonal Influenza Vaccines Market & Forecast

6.2 Japan

6.2.1 Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.2.2 Japan – Seasonal Influenza Vaccines Market & Forecast

6.3 China

6.3.1 China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.3.2 China – Seasonal Influenza Vaccines Market & Forecast

6.4 India

6.4.1 India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.4.2 India – Seasonal Influenza Vaccines Market & Forecast

6.5 Brazil

6.5.1 Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.5.2 Brazil – Seasonal Influenza Vaccines Market & Forecast

6.6 Netherlands

© Renub Research Page 8 of 21

6.6.1 Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.6.2 Netherlands – Seasonal Influenza Vaccines Market & Forecast

6.7 Germany

6.7.1 Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.7.2 Germany – Seasonal Influenza Vaccines Market & Forecast

6.8 France

6.8.1 France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.8.2 France – Seasonal Influenza Vaccines Market & Forecast

6.9 Italy

6.9.1 Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.9.2 Italy – Seasonal Influenza Vaccines Market & Forecast

6.10 Spain

6.10.1 Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.10.2 Spain – Seasonal Influenza Vaccines Market & Forecast

6.11 Denmark

6.11.1 Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.11.2 Denmark – Seasonal Influenza Vaccines Market & Forecast

6.12 Sweden

6.12.1 Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.12.2 Sweden – Seasonal Influenza Vaccines Market & Forecast

6.13 Portugal

6.13.1 Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.13.2 Portugal – Seasonal Influenza Vaccines Market & Forecast

6.14 Luxembourg

6.14.1 Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.14.2 Luxembourg – Seasonal Influenza Vaccines Market & Forecast

6.15 Lithuania

6.15.1 Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.15.2 Lithuania – Seasonal Influenza Vaccines Market & Forecast

6.16 United Kingdom

6.16.1 United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.16.2 United Kingdom – Seasonal Influenza Vaccines Market & Forecast

6.17 Poland

6.17.1 Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

© Renub Research Page 9 of 21

6.17.2 Poland – Seasonal Influenza Vaccines Market & Forecast

6.18 Norway

6.18.1 Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.18.2 Norway – Seasonal Influenza Vaccines Market & Forecast

6.19 Romania

6.19.1 Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.19.2 Romania – Seasonal Influenza Vaccines Market & Forecast

6.20 Estonia

6.20.1 Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.20.2 Estonia – Seasonal Influenza Vaccines Market & Forecast

6.21 Finland

6.21.1 Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.21.2 Finland – Seasonal Influenza Vaccines Market & Forecast

6.22 Hungary

6.22.1 Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.22.2 Hungary – Seasonal Influenza Vaccines Market & Forecast

6.23 Ireland

6.23.1 Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.23.2 Ireland – Seasonal Influenza Vaccines Market & Forecast

6.24 Iceland

6.24.1 Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.24.2 Iceland – Seasonal Influenza Vaccines Market & Forecast

6.25 Latvia

6.25.1 Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.25.2 Latvia – Seasonal Influenza Vaccines Market & Forecast

6.26 Malta

6.26.1 Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.26.2 Malta – Seasonal Influenza Vaccines Market & Forecast

6.27 Slovakia

6.27.1 Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.27.2 Slovakia – Seasonal Influenza Vaccines Market & Forecast

6.28 Slovenia

6.28.1 Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.28.2 Slovenia – Seasonal Influenza Vaccines Market & Forecast

© Renub Research Page 10 of 21

6.29 Australia

6.29.1 Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.29.2 Australia – Seasonal Influenza Vaccines Market & Forecast

6.30 New Zealand

6.30.1 New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

6.30.2 New Zealand – Seasonal Influenza Vaccines Market & Forecast

7. Worldwide – Seasonal Influenza Vaccine Brand Sales & Forecast

7.1 Fluarix / Flulaval – Sales Performance & Forecast

7.2 Afluria/Fluvax – Sales Performance & Forecast

7.3 FluMist/Fluenz – Sales Performance & Forecast

7.4 Influvac (Now Acquired by Abbott) – Sales Performance & Forecast

7.5 Fluvirin / Flucelvax – Sales Performance & Forecast

7.6 Fluzone – Sales Performance & Forecast

8. Growth Drivers in the Influenza Vaccines Market

8.1 Transforming Vaccine Technologies

8.2 Continuous Focus on Effective Communication Strategies

8.3 Vaccines most Cost Effective Means of Disease Prevention

8.4 Scientific & Technological Breakthroughs

8.5 Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in

European Countries

9. Challenges for Influenza Vaccine Market

9.1 Obstacle to Best Possible use of Licensed Vaccines

9.1.1 Economic Obstacles

9.1.2 Technical Obstacles

9.1.3 Cultural Obstacles

9.2 Difficulty of Influenza Vaccine Development & Approval System

9.2.1 General Technical Barriers

9.2.2 Economic Barriers

9.2.3 Legal Barriers

9.2.4 Regulatory Barriers

9.3 Reducing the Timeline for Vaccine Development

© Renub Research Page 11 of 21

9.4 Problem Faced by Healthcare Workers in Immunization

© Renub Research Page 12 of 21

List of Figures

Figure 2-1: Worldwide – Influenza Vaccines Market (Million US$), 2009 – 2013

Figure 2-2: Worldwide – Forecast for Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 2-3: Worldwide – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million),

2009 – 2013

Figure 2-4: Worldwide – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Million), 2014 – 2019

Figure 3-1: Worldwide – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013

Figure 3-2: Worldwide – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 4-1: Worldwide – Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 – 2011

Figure 5-1: Segment wise – Influenza Vaccines Market Share (Percent), 2009 – 2013

Figure 5-2: Segment wise – Forecast for Influenza Vaccines Market Share (Percent), 2014 – 2019

Figure 6-1: United States – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2009 – 2013

Figure 6-2: United States – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-3: United States – Seasonal Influenza Vaccines Market (Million US$), 2009 – 2013

Figure 6-4: United States – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-5: Japan – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008 – 2013

Figure 6-6: Japan – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-7: Japan – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-8: Japan – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-9: China – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008–2013

Figure 6-10: China – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-11: China – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-12: China – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-13: India – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008 – 2013

Figure 6-14: India – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-15: India – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-16: India – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research Page 13 of 21

Figure 6-17: Brazil – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008 – 2013

Figure 6-18: Brazil – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-19: Brazil – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-20: Brazil – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-21: Netherlands – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-22: Netherlands – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-23: Netherlands – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-24: Netherlands – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-25: Germany – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-26: Germany – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-27: Germany – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-28: Germany – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-29: France – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-30: France – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-31: France – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-32: France – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-33: Italy – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008 – 2013

Figure 6-34: Italy – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-35: Italy – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-36: Italy – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-37: Spain – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008 – 2013

Figure 6-38: Spain – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-39: Spain – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-40: Spain – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research Page 14 of 21

Figure 6-41: Denmark – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-42: Denmark – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-43: Denmark – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-44: Denmark – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-45: Sweden – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-46: Sweden – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-47: Sweden – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-48: Sweden – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-49: Portugal – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-50: Portugal – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-51: Portugal – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-52: Portugal – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-53: Luxembourg – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-54: Luxembourg – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-55: Luxembourg – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-56: Luxembourg – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-57: Lithuania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-58: Lithuania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-59: Lithuania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-60: Lithuania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-61: United Kingdom – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-62: United Kingdom – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-63: United Kingdom – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-64: United Kingdom – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 –

2019

© Renub Research Page 15 of 21

Figure 6-65: Poland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-66: Poland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-67: Poland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-68: Poland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-69: Norway – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-70: Norway – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-71: Norway – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-72: Norway – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-73: Romania – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-74: Romania – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-75: Romania – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-76: Romania – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-77: Estonia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-78: Estonia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-79: Estonia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-80: Estonia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-81: Finland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-82: Finland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-83: Finland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-84: Finland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-85: Hungary – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-86: Hungary – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-87: Hungary – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-88: Hungary – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research Page 16 of 21

Figure 6-89: Ireland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008–2013

Figure 6-90: Ireland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-91: Ireland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-92: Ireland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-93: Iceland – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-94: Iceland – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-95: Iceland – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-96: Iceland – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-97: Latvia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008 – 2013

Figure 6-98: Latvia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-99: Latvia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-100: Latvia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-101: Malta – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand),

2008 – 2013

Figure 6-102: Malta – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2014 – 2019

Figure 6-103: Malta – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-104: Malta – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-105: Slovakia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-106: Slovakia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-107: Slovakia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-108: Slovakia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-109: Slovenia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-110: Slovenia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-111: Slovenia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-112: Slovenia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

© Renub Research Page 17 of 21

Figure 6-113: Australia – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-114: Australia – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-115: Australia – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-116: Australia – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 6-117: New Zealand – Number of Persons Being Vaccinated with Seasonal Influenza Vaccines

(Thousand), 2008 – 2013

Figure 6-118: New Zealand – Forecast for Number of Persons Being Vaccinated with Seasonal Influenza

Vaccines (Thousand), 2014 – 2019

Figure 6-119: New Zealand – Seasonal Influenza Vaccines Market (Million US$), 2008 – 2013

Figure 6-120: New Zealand – Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 – 2019

Figure 7-1: Worldwide – Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 – 2013

Figure 7-2: Worldwide – Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$),

2014 – 2019

Figure 7-3: Worldwide – Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 – 2013

Figure 7-4: Worldwide – Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014

– 2019

Figure 7-5: Worldwide – Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013

Figure 7-6: Worldwide – Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014

– 2019

Figure 7-7: Worldwide – Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 – 2009

Figure 7-8: Worldwide – Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 – 2013

Figure 7-9: Worldwide – Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$),

2014 – 2019

Figure 7-10: Worldwide – Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 – 2013

Figure 7-11: Worldwide – Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014 –

2019

© Renub Research Page 18 of 21

List of Tables

Table 2-1: Worldwide – Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 – 2011

Table 5-1: Countries wise – Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines

Share (Percent), 2009 – 2013

Table 5-2: Countries wise – Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza

Vaccines Share (Percent), 2014 – 2019

Table 5-3: Countries wise – Seasonal Influenza Vaccines Market Share (Percent), 2009 – 2013

Table 5-4: Countries wise – Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014 –

2019

Table 8-1: Improvement Strategies or Requirements – the Joint Commission and the Project’s

Collaborating Organizations

Table 8-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to

Seasonal Influenza in European Countries, 2009

© Renub Research Page 19 of 21

Order Form

Scan and e-mail this page to [email protected], alternatively one can also write the Contact

Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

[email protected]

Format

Report Title: Influenza Vaccines Market & Forecast - Worldwide Analysis

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,490 US$ 1,640 US$ 1,590 US$ 2,490

For ordering this report: Three easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):

http://www.renub.com/report/influenza-vaccines-market-forecast---worldwide-analysis-151

2) Order by Wire Transfer:

http://www.renub.com/report/wiretransfer.aspx?id=151&pid=1574

To pay by Wire Transfer, please, fill in your contact details in the form below:

© Renub Research Page 20 of 21

Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India

Contact Information

First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:

© Renub Research Page 21 of 21

3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor

C-86, Sector -10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090

LinkedIn: http://www.linkedin.com/company/renub-research

Twitter: http://twitter.com/RenubResearch